// App-Quantinova.ai

: IL-36? – a key mediator of neutrophilic inflammation in chronic obstructive pulmonary disease

Researchers

Presenter

  • Jonathan R. Baker

Principal Investigators

  • Peter S Fenwick

  • Harriet B Owles

  • Carolin Koss

  • Karim El-Kasmi

  • Peter J Barnes

  • Louise E Donnelly

Medical Centers

  • Boehringer Ingelheim Pharma GmbH and Co. KG, Biberach, Germany

  • Imperial College, London, United Kingdom

Locations

  • Germany

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Chronic obstructive pulmonary disease

Biomarkers

  • Cytokine

  • Interleukin-36

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved